Clinical and molecular epidemiology of hepatitis C virus in North-Eastern India: occurrence of 4a as the major subtype

被引：0
|
作者：
Medhi, S. [1 ]
Singh, B. [2 ]
Das, A. [3 ]
Goswami, B. [4 ]
Kar, P. [1 ]
机构：
[1] Maulana Azad Med Coll, Dept Med, PCR Hepatitis Lab, New Delhi, India
[2] Reg Med Coll Imphal, Dept Med, Imphal, Manipur, India
[3] Assam Med Coll, Dept Med, Dibrugarh, Assam, India
[4] Guwahati Med Coll, Dept Gastroenterol, Gauhati, Assam, India
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 48 条
  • [41] Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease
    Ejeh, Stephen
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Abechi, Stephen Eyije
    Ibrahim, Muhammad Tukur
    Ramu, Ramith
    Al-Ghorbani, Mohammed
    [J]. SCIENTIFIC AFRICAN, 2023, 20
  • [42] Understanding of the drug resistance mechanism of hepatitis C virus NS3/4A to paritaprevir due to D168N/Y mutations: A molecular dynamics simulation perspective
    Boonma, Thitiya
    Nutho, Bodee
    Rungrotmongkol, Thanyada
    Nunthaboot, Nadtanet
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 83
  • [43] Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4a) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains (vol 9, e104425, 2014)
    Kramer, M.
    Halleran, D.
    Rahman, M.
    Iqbal, M.
    Anwar, M., I
    [J]. PLOS ONE, 2014, 9 (12):
  • [44] In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir (vol 57, e01844-18, 2019)
    Han, Bin
    Parhy, Bandita
    Lu, Julia
    Zhou, Eric
    Hsieh, David
    Camus, Gregory
    Martin, Ross
    Svarovskaia, Evguenia S.
    Mo, Hongmei
    Dvory-Sobol, Hadas
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (07)
  • [45] Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4b) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains
    Kramer, Mitchell
    Halleran, Daniel
    Rahman, Moazur
    Iqbal, Mazhar
    Anwar, Muhmad Ikram
    Sabet, Salwa
    Ackad, Edward
    Yousef, Mohammad
    [J]. PLOS ONE, 2014, 9 (08):
  • [46] Characteristics of adults with difficult-to-treat hepatitis C virus genotype subtype 4r infection in Rwanda: a secondary analysis of a clinical trial in Sub-Saharan Africa (shared study)
    Kateera, Fredrick
    Shumbusho, Fabienne
    Liu, Anne
    Umutesi, Grace
    Kabahizi, Jules
    Nsanzimana, Sabin
    Serumondo, Janvier
    Damascene, Makuza Jean
    Grant, Philip
    Muvunyi, Claude
    Gupta, Neil
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S340 - S341
  • [47] The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity
    Wang, Shuni
    Wang, Yibing
    Wang, Jiang
    Sato, Tatsunori
    Izawa, Kunisuke
    Soloshonok, Vadim A.
    Liu, Hong
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (30) : 4493 - 4554
  • [48] Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4b) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains (vol 9, e111263, 2014)
    Kramer, M.
    Halleran, D.
    Rahman, M.
    Iqbal, M.
    Anwar, M., I
    Yousef, Mohammad S.
    [J]. PLOS ONE, 2014, 9 (10):
12345